IL161623A0 - Nicotin-or isonicotin benzothiazole derivatives - Google Patents

Nicotin-or isonicotin benzothiazole derivatives

Info

Publication number: IL161623A0
Authority: IL; Israel
Prior art keywords: isonicotin; nicotin; benzothiazole derivatives; benzothiazole; derivatives
Prior art date: 2001-11-19

Application number

IL16162302A

Other languages

English (en)

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-19

Filing date

2002-11-11

Publication date

2004-09-27

2002-11-11 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2004-09-27 Publication of IL161623A0 publication Critical patent/IL161623A0/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Addiction (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Rheumatology (AREA)
Immunology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

IL16162302A 2001-11-19 2002-11-11 Nicotin-or isonicotin benzothiazole derivatives IL161623A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01127312		2001-11-19
PCT/EP2002/012562 WO2003043636A1 (fr)	2001-11-19	2002-11-11	Derives de nicotine ou d'isonicotine benzothiazole

Publications (1)

Publication Number	Publication Date
IL161623A0 true IL161623A0 (en)	2004-09-27

Family

ID=8179263

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL16162302A IL161623A0 (en)	2001-11-19	2002-11-11	Nicotin-or isonicotin benzothiazole derivatives
IL161623A IL161623A (en)	2001-11-19	2004-04-26	Nicotin-or isonicotin benzothiazole derivatives, their preparation and pharmaceutical compositions comprising them

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL161623A IL161623A (en)	2001-11-19	2004-04-26	Nicotin-or isonicotin benzothiazole derivatives, their preparation and pharmaceutical compositions comprising them

Country Status (38)

Country	Link
US (1)	US6620811B2 (fr)
EP (1)	EP1448198B1 (fr)
JP (1)	JP4226474B2 (fr)
KR (1)	KR100577110B1 (fr)
CN (1)	CN100546580C (fr)
AR (1)	AR039367A1 (fr)
AT (1)	ATE376831T1 (fr)
AU (1)	AU2002351955B2 (fr)
BR (1)	BR0214245A (fr)
CA (1)	CA2467552C (fr)
DE (1)	DE60223278T2 (fr)
DK (1)	DK1448198T3 (fr)
EA (1)	EA007502B1 (fr)
EC (1)	ECSP045109A (fr)
ES (1)	ES2294187T3 (fr)
GT (1)	GT200200232A (fr)
HR (1)	HRP20040396A2 (fr)
HU (1)	HUP0402161A3 (fr)
IL (2)	IL161623A0 (fr)
JO (1)	JO2290B1 (fr)
MA (1)	MA27083A1 (fr)
MX (1)	MXPA04004684A (fr)
MY (1)	MY126176A (fr)
NO (1)	NO20042576L (fr)
NZ (1)	NZ532802A (fr)
PA (1)	PA8558001A1 (fr)
PE (1)	PE20030713A1 (fr)
PL (1)	PL369517A1 (fr)
PT (1)	PT1448198E (fr)
RS (1)	RS39904A (fr)
RU (1)	RU2294933C2 (fr)
SI (1)	SI1448198T1 (fr)
TN (1)	TNSN04087A1 (fr)
TW (1)	TW200407134A (fr)
UA (1)	UA77462C2 (fr)
UY (1)	UY27542A1 (fr)
WO (1)	WO2003043636A1 (fr)
ZA (1)	ZA200403817B (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2001281817B2 (en) *	2000-06-21	2005-11-24	F. Hoffmann-La Roche Ag	Benzothiazole derivatives
WO2002100434A1 (fr) *	2001-06-07	2002-12-19	The General Hospital Corporation	Traitement de la douleur nevropathique avec des antagonistes du recepteur n-methyl-d-aspartate (nmda)
US6734179B2 (en) *	2001-12-12	2004-05-11	Hoffmann-La Roche Inc.	Benzothiazoles
US7390813B1 (en)	2001-12-21	2008-06-24	Xenon Pharmaceuticals Inc.	Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents
US20050119251A1 (en) *	2001-12-21	2005-06-02	Jian-Min Fu	Nicotinamide derivatives and their use as therapeutic agents
US6872833B2 (en)	2003-04-14	2005-03-29	Hoffmann-La Roche Inc.	Adenosine receptor ligands
TWI376370B (en)	2003-07-23	2012-11-11	Synta Pharmaceuticals Corp	Compounds for inflammation and immune-related uses
PL1648874T3 (pl)	2003-07-30	2012-04-30	Xenon Pharmaceuticals Inc	Pochodne piperazyny i ich zastosowanie jako środków leczniczych
RU2006112847A (ru)	2003-09-19	2007-11-10	Ф. Хоффманн-Ля Рош Аг (Ch)	Производные тиазолопиридина в качестве лигандов аденозинового рецептора
EP1677791A4 (fr) *	2003-10-31	2007-08-15	Takeda Pharmaceutical	Composes heterocycliques accoles contenant de l'azote
JP4638355B2 (ja)	2003-12-26	2011-02-23	協和発酵キリン株式会社	チアゾール誘導体
ATE537830T1 (de) *	2004-07-06	2012-01-15	Xenon Pharmaceuticals Inc	Nicotinamid derivate und ihre verwendung als therapeutika
KR100823799B1 (ko) *	2004-07-22	2008-04-21	에프. 호프만-라 로슈 아게	벤조티아졸 유도체
CN1989117B (zh) *	2004-07-22	2011-01-19	弗·哈夫曼-拉罗切有限公司	取代的苯并噻唑
JP5202946B2 (ja) *	2004-07-22	2013-06-05	エフ．ホフマン−ラロシュアーゲー	ベンゾチアゾール誘導体
AU2005286790A1 (en) *	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-CoA-desaturase (SCD)
CN101084211A (zh) *	2004-09-20	2007-12-05	泽农医药公司	杂环衍生物及其作为治疗剂的用途
BRPI0515482A (pt) *	2004-09-20	2008-07-22	Xenon Pharmaceuticals Inc	derivados heterocìclicos e seus usos como agentes terapêuticos
AU2005286728A1 (en) *	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
BRPI0515500A (pt) *	2004-09-20	2008-07-29	Xenon Pharmaceuticals Inc	derivados piridazina para inibição de estearoil-coa-desaturase
EP1827438B2 (fr) †	2004-09-20	2014-12-10	Xenon Pharmaceuticals Inc.	Derives de la piperazine et leur utilisation comme agents therapeutiques
MX2007003318A (es)	2004-09-20	2007-05-18	Xenon Pharmaceuticals Inc	Derivados heterociclicos y su uso como agentes terapeuticos.
AU2005286647A1 (en) *	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
MX2007003332A (es) *	2004-09-20	2007-06-05	Xenon Pharmaceuticals Inc	Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa.
ES2309814T3 (es) *	2004-11-05	2008-12-16	F. Hoffmann-La Roche Ag	Proceso para la obtencion de derivados del acido isonicotinico.
US20060223849A1 (en) *	2005-03-14	2006-10-05	Mjalli Adnan M	Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors
CA2618646A1 (fr) *	2005-06-03	2007-11-15	Xenon Pharmaceuticals Inc.	Derives aminothiazole utilises en tant qu'inhibiteurs de la stearoyle-coa desaturase humaine
CN101583593A (zh) *	2006-11-13	2009-11-18	辉瑞产品公司	二芳基、二吡啶基和芳基-吡啶基衍生物及其用途
JP2012525389A (ja)	2009-04-27	2012-10-22	ハイポイントファーマシューティカルズ，リミティドライアビリティカンパニー	置換イソキノリン誘導体、医薬組成物、及びβ−セクレターゼ阻害剤としての使用方法
TWI548411B (zh)	2009-04-28	2016-09-11	Kyowa Hakko Kirin Co Ltd	Exercise disorder treatment
UA110097C2 (uk)	2009-09-02	2015-11-25		Терапевтичний агент для лікування розладів настрою
UA113383C2 (xx)	2009-09-02	2017-01-25		Терапевтичний агент для лікування тривожних розладів
EP2549874A4 (fr) *	2010-03-23	2013-10-02	High Point Pharmaceuticals Llc	Dérivés d'imidazole[1,2-b]pyridazine substitués, compositions pharmaceutiques et procédés d'utilisation en tant qu'inhibiteurs de bêta-sécrétase
JP5248585B2 (ja) *	2010-12-15	2013-07-31	ゼノン・ファーマシューティカルズ・インコーポレイテッド	治療薬としてのニコチンアミド誘導体およびそれらの使用
DE102011005232A1 (de)	2011-03-08	2012-09-13	AristoCon GmbH & Co. KG	Adenosin und seine Derivate zur Verwendung in der Schmerztherapie
DK2903968T3 (en) *	2012-10-02	2017-01-30	Gilead Sciences Inc	INHIBITORS OF HISTON DEMETHYLASES
CN111205244B (zh) *	2018-11-22	2023-08-18	上海科技大学	噻唑并环类化合物、其制备方法、中间体和应用
DE102019110904B4 (de) *	2019-04-26	2022-01-20	Helmholtz-Zentrum Dresden - Rossendorf E. V.	N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-acetamid-Derivate und deren Verwendung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3374550D1 (en)	1982-12-21	1987-12-23	Johnsen Jorgensen Plastics Ltd	Dispensing container
FI91859C (fi) *	1987-06-17	1994-08-25	Eisai Co Ltd	Analogiamenetelmä antiallergisena aineena aktiivisen bentsotiatsolijohdannaisen valmistamiseksi
IL90337A0 (en) *	1988-05-24	1989-12-15	Pfizer	Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents
AU2001281817B2 (en)	2000-06-21	2005-11-24	F. Hoffmann-La Roche Ag	Benzothiazole derivatives

2002
- 2002-11-05 US US10/288,100 patent/US6620811B2/en not_active Expired - Lifetime
- 2002-11-11 HR HR20040396A patent/HRP20040396A2/hr not_active Application Discontinuation
- 2002-11-11 EA EA200400598A patent/EA007502B1/ru not_active IP Right Cessation
- 2002-11-11 ES ES02787632T patent/ES2294187T3/es not_active Expired - Lifetime
- 2002-11-11 EP EP02787632A patent/EP1448198B1/fr not_active Expired - Lifetime
- 2002-11-11 PT PT02787632T patent/PT1448198E/pt unknown
- 2002-11-11 AU AU2002351955A patent/AU2002351955B2/en not_active Ceased
- 2002-11-11 BR BR0214245-7A patent/BR0214245A/pt not_active IP Right Cessation
- 2002-11-11 CN CNB028228391A patent/CN100546580C/zh not_active Expired - Fee Related
- 2002-11-11 JP JP2003545317A patent/JP4226474B2/ja not_active Expired - Fee Related
- 2002-11-11 CA CA2467552A patent/CA2467552C/fr not_active Expired - Fee Related
- 2002-11-11 MX MXPA04004684A patent/MXPA04004684A/es active IP Right Grant
- 2002-11-11 DE DE60223278T patent/DE60223278T2/de not_active Expired - Lifetime
- 2002-11-11 IL IL16162302A patent/IL161623A0/xx unknown
- 2002-11-11 UA UA20040604552A patent/UA77462C2/uk unknown
- 2002-11-11 HU HU0402161A patent/HUP0402161A3/hu not_active Application Discontinuation
- 2002-11-11 RS YU39904A patent/RS39904A/sr unknown
- 2002-11-11 PL PL02369517A patent/PL369517A1/xx not_active Application Discontinuation
- 2002-11-11 AT AT02787632T patent/ATE376831T1/de active
- 2002-11-11 DK DK02787632T patent/DK1448198T3/da active
- 2002-11-11 SI SI200230637T patent/SI1448198T1/sl unknown
- 2002-11-11 WO PCT/EP2002/012562 patent/WO2003043636A1/fr not_active Ceased
- 2002-11-11 KR KR1020047007638A patent/KR100577110B1/ko not_active Expired - Fee Related
- 2002-11-11 RU RU2004118425/04A patent/RU2294933C2/ru not_active IP Right Cessation
- 2002-11-11 NZ NZ532802A patent/NZ532802A/en unknown
- 2002-11-14 PA PA20028558001A patent/PA8558001A1/es unknown
- 2002-11-14 TW TW091133371A patent/TW200407134A/zh unknown
- 2002-11-15 PE PE2002001104A patent/PE20030713A1/es not_active Application Discontinuation
- 2002-11-18 MY MYPI20024303A patent/MY126176A/en unknown
- 2002-11-18 AR ARP020104416A patent/AR039367A1/es unknown
- 2002-11-18 UY UY27542A patent/UY27542A1/es not_active Application Discontinuation
- 2002-11-18 GT GT200200232A patent/GT200200232A/es unknown
- 2002-11-18 JO JO2002114A patent/JO2290B1/en active
2004
- 2004-04-26 IL IL161623A patent/IL161623A/en not_active IP Right Cessation
- 2004-05-17 EC EC2004005109A patent/ECSP045109A/es unknown
- 2004-05-18 TN TNP2004000087A patent/TNSN04087A1/en unknown
- 2004-05-18 MA MA27681A patent/MA27083A1/fr unknown
- 2004-05-18 ZA ZA200403817A patent/ZA200403817B/en unknown
- 2004-06-18 NO NO20042576A patent/NO20042576L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
KR20050044535A (ko)	2005-05-12
IL161623A (en)	2010-11-30
BR0214245A (pt)	2004-12-14
NO20042576L (no)	2004-06-18
MXPA04004684A (es)	2004-08-12
AR039367A1 (es)	2005-02-16
ZA200403817B (en)	2005-05-23
AU2002351955A1 (en)	2003-06-10
RU2004118425A (ru)	2006-01-10
US6620811B2 (en)	2003-09-16
JO2290B1 (en)	2005-09-12
MY126176A (en)	2006-09-29
HRP20040396A2 (en)	2005-04-30
EP1448198B1 (fr)	2007-10-31
EA007502B1 (ru)	2006-10-27
CN100546580C (zh)	2009-10-07
AU2002351955B2 (en)	2007-03-15
PL369517A1 (en)	2005-04-18
RU2294933C2 (ru)	2007-03-10
GT200200232A (es)	2003-06-17
PA8558001A1 (es)	2003-07-28
ATE376831T1 (de)	2007-11-15
TW200407134A (en)	2004-05-16
JP2005522413A (ja)	2005-07-28
PT1448198E (pt)	2007-12-11
ES2294187T3 (es)	2008-04-01
HUP0402161A3 (en)	2010-06-28
CA2467552C (fr)	2011-05-24
UA77462C2 (en)	2006-12-15
DE60223278D1 (de)	2007-12-13
EP1448198A1 (fr)	2004-08-25
DK1448198T3 (da)	2008-01-07
NZ532802A (en)	2005-07-29
PE20030713A1 (es)	2003-08-23
MA27083A1 (fr)	2004-12-20
JP4226474B2 (ja)	2009-02-18
WO2003043636A1 (fr)	2003-05-30
DE60223278T2 (de)	2008-08-14
EA200400598A1 (ru)	2005-02-24
CN1617722A (zh)	2005-05-18
TNSN04087A1 (en)	2006-06-01
ECSP045109A (es)	2004-06-28
US20030134854A1 (en)	2003-07-17
CA2467552A1 (fr)	2003-05-30
RS39904A (sr)	2006-10-27
SI1448198T1 (sl)	2008-02-29
HUP0402161A2 (hu)	2005-02-28
UY27542A1 (es)	2003-05-30
KR100577110B1 (ko)	2006-05-10

Publication	Publication Date	Title
IL161623A0 (en)	2004-09-27	Nicotin-or isonicotin benzothiazole derivatives
PL370978A1 (en)	2005-06-13	Benzothiazole derivatives
HRP20020962A2 (en)	2005-02-28	Benzothiazole derivatives
EP1392664A4 (fr)	2005-01-26	Derives d'epothilone
IL160701A0 (en)	2004-08-31	3-substituted-4-pyrimidone derivatives
PL372123A1 (en)	2005-07-11	Thiazole derivatives
ZA200309522B (en)	2005-02-23	Substituted cyclohexane-1-4diamine derivatives
AP1850A (en)	2008-05-26	Spiroindolineplperidine derivatives
IL190341A0 (en)	2009-09-22	Heterocyclocarboxamide derivatives
EP1522540A4 (fr)	2011-08-10	Derives d'azaarene
PL376475A1 (en)	2005-12-27	N-substituted-2-oxodihydropyridine derivatives
IL158388A0 (en)	2004-05-12	Novel arylheteroalkylamine derivatives
IL166426A0 (en)	2006-01-15	N-biarylmethyl aminocycloalkanecarboxamide derivatives
HUP0303449A3 (en)	2005-02-28	Substituted benzofuran-2-carboxamides derivatives
PL375416A1 (en)	2005-11-28	Thiazole derivatives
HUP0401949A3 (en)	2009-07-28	4-imidazolin-2-one derivatives
HUP0303186A3 (en)	2007-06-28	4-aminobenzopyran derivatives
HUP0500026A3 (en)	2008-02-28	N-heteroarylnicotinamide derivatives
AU2003222659A8 (en)	2003-11-03	23-o-substituted 5-o-mycaminosyltylonide derivatives
PL373947A1 (en)	2005-09-19	Benzothiazole derivatives
AU2003294938A8 (en)	2004-07-14	Epothilone derivatives
DE60207294D1 (en)	2005-12-15	Benzothiazole
IL159064A0 (en)	2004-05-12	New phenylalkyloxy- phenyl derivatives
EP1364954A4 (fr)	2009-10-28	Derives de dicarba-(closo)-dodecarborane
EP1531854A4 (fr)	2006-06-28	Derives de nocathiacine o-derivatises